Researchers from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) have found that a naturally occurring compound called spermidine may help improve vaccine responses in some older adults by reducing signs of immune system ageing.
The first study of England's harmonised education tariff finds equal funding has expanded GP placements and strengthened teaching quality \u2013 and identifies what must be protected as NHS England's functions transfer to the Department of Health and Social Care.
The largest and longest clinical trial of its kind has found that resurfacing the kneecap during total knee replacement is likely to be the most cost-effective approach for patients and healthcare systems over the long term.
The University of Oxford is set to launch a new research centre dedicated to women\u2019s mental health, bringing together expertise from medical and biological sciences with humanities for the first time.
This week the UK government announced a ban on social media for under-16s and new age limits on romantic and sexual AI chatbots, following the precedent set by Australia. Researchers from the University of Oxford's Department of Psychiatry welcome the focus on children's online safety, but argue that age limits alone are a limited safeguard, and that protecting children depends more on how platforms and AI systems are designed than on who can reach them.
Oxford Cancer is delighted to announce the appointment of Professor Adam Mead as Director, joining Professors Mark Middleton and Tim Elliott in leading Oxford\u2019s interdisciplinary cancer research community.
A new study led by Professor Geoff Higgins at the Department of Oncology, in collaboration with Artios Pharma, has uncovered a genetic vulnerability that could help identify patients most likely to benefit from a promising radiotherapy combination treatment. Published today in Science Advances, the research identifies loss of SHLD2 as a predictive biomarker for treatment with DNA polymerase theta (Pol\u03b8) inhibitors, an emerging class of DNA repair-targeted drugs.
In an important discovery for the next-generation of malaria vaccines, University of Oxford researchers in the Department of Paediatrics, in collaboration with the Scripps Institute, have identified how antibodies can be over 90% effective at preventing malaria parasites from growing in certain combinations.
The winners of the 2026 Vice-Chancellor\u2019s Awards were announced at a special ceremony hosted by the Vice-Chancellor in the Schwarzman\u2019s Sohmen Concert Hall on Thursday 4 June.
Leading experts from the University of Oxford and the World Health Organization are calling on the global community to invest in affordable proven solutions and change policy to end preventable deaths from bleeding during childbirth.
A major new research programme, led by Professor Ruth Travis and Dr Karl Smith-Byrne (Nuffield Department of Population Health) and funded by Cancer Research UK, aims to uncover the biological causes of prostate cancer and identify ways to prevent the disease. The programme is being delivered through a collaboration between researchers in the Nuffield Department of Population Health and the Nuffield Department of Surgical Sciences (NDS).
Scientists have identified the missing link between a long-known genetic signal in inflammatory bowel disease and a damaging immune response that switches off the body\u2019s natural control of inflammation - opening the door to faster diagnosis and targeted treatment.
Researchers from the Department of Pharmacology have found that the \u2018neural compass\u2019 that enables mice to navigate is formed of specialised brain cells that respond in different ways to stimuli such as light and sound.
Oxford researchers will test an AI-powered triage system that draws on patients' medical histories to help GP teams prioritise urgent same-day care. The project is funded by the NIHR as part of an \u00a38.1 million investment in digital technologies to reduce NHS waiting times.
Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna, sponsored by the University of Oxford and run by the University's Oncology Clinical Trials Office with support from Oxford Cancer, has received authorisation from the Medicines and Healthcare products Regulatory Agency and is expected to begin recruiting participants this summer.
Professor Gaia Scerif from the Department of Experimental Psychology is a key partner in a newly announced research centre that will help shape education policy across England.
Professor Marian Knight, Director of the National Perinatal Epidemiology Unit (NPEU), appeared on BBC Breakfast on 5th June to discuss new NPEU research examining recent changes in caesarean birth rates in England.
Professor Emma Slack, Professor of Molecular Immunology, at the Dunn School and collaborators have developed a preventive approach that stops harmful bacteria in their tracks before transmission even occurs.
A new opinion article published in Trends in Cell Biology explores how tiny packages released by cells, known as exosomes, could help researchers better understand disease and may one day support new approaches to diagnosis and treatment.
![\"Foods](\"https://www.medsci.ox.ac.uk/news/natural-compound-may-help-boost-vaccine-responses-in-older-adults/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n